{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-23-000056","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2023-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.692014+00:00","generated_at":"2026-06-11T06:03:10.123001+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Supernus appoints Bethany L. Sensenig to Board of Directors","bullets":["Ms. Sensenig appointed as independent director and Audit Committee member effective August 17, 2023.","2023 compensation: $62,500 prorated for service plus options to buy 24,153 shares at $30.22 (4-year vest).","Board expands to seven members; Ms. Sensenig brings 20+ years pharma/biotech financial leadership.","Former CFO/Interim CEO of 9 Meters Biopharma and VP Finance & Commercial Ops at Biogen."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-23-000056","json":"https://secwatch.observer/filing/0001356576-23-000056.json","markdown":"https://secwatch.observer/filing/0001356576-23-000056.md","text":"https://secwatch.observer/filing/0001356576-23-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/0001356576-23-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/supn-20230817.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:03:10.123001+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8fd0d40b38","claim":"Bethany L. Sensenig was appointed as member of the Board of Directors at SUPERNUS PHARMACEUTICALS, INC..","evidence_excerpt":"As of August 17, 2023, the Board of Directors of Supernus Pharmaceuticals, Inc. (the “Company”) appointed Bethany L. Sensenig as a member of the Board of Directors of the Company and as a member of the Audit Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356576/000135657623000056/0001356576-23-000056-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}